for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Pfizer Sees $18 - $20 Bln Lost Revenue Due To Exclusivity Losses Beginning In 2026 - Investor Day

Sept 14 (Reuters) - Pfizer Inc:

* PFIZER CEO SAYS STILL SEES AT LEAST 6% CAGR GROWTH OVER THE NEXT 5 YRS - INVESTOR DAY

* PFIZER SEES $18 - $20 BILLION LOST REVENUE DUE TO EXCLUSIVITY LOSSES BEGINNING IN 2026; SAYS CURRENT PIPELINE EXPECTED TO AT LEAST REPLACE THAT REVENUE - INVESTOR DAY

* PFIZER EXEC SAYS EXPECTS HEART DRUG VYNDAQEL TO BE CLOSE TO A $1 BILLION GLOBAL BRAND BY THE END OF 2020 - INVESTOR DAY Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up